Angiocrine Bioscience

About:

Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models.

Website: http://www.angiocrinebioscience.com

Twitter/X: angiocrine

Top Investors: Gutbrain Ventures, California Institute for Regenerative Medicine

Description:

Angiocrine Bioscience has developed a cellular platform for amplifying stem and progenitor cells, in both human and mouse models, by recapitulating the proliferative stimulation of the in vivo vascular niche in vitro. The expansion capacity is on an unprecedented scale when compared to any other competing technology, and it is achieved without the requirement for costly media additives. This process can meet the needs of a broad range of therapeutic, diagnostic, and research applications. We look forward to the expansive application of this technology to help fulfill the promise of tissue-specific engineering and organ-regeneration.